Drugs and the liver

被引：6

作者：

Rashid, M

Goldin, R

Wright, M ^{[1
]}

机构：

[1] Queen Elizabeth Hosp 2, Welwyn Garden City, Herts, England

[2] Univ London Imperial Coll Sci Technol & Med, London, England

来源：

HOSPITAL MEDICINE | 2004年 / 65卷 / 08期

关键词：

D O I：

10.12968/hosp.2004.65.8.15489

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This article discusses the classification, epidemiology, mechanisms and pathology of drug-induced liver disease. A number of specific examples involving commonly used drugs are discussed.

引用

页码：456 / 461

页数：6

共 9 条

[1]

BENICHOU C, 1990, J HEPATOL, V11, P272

[2]

*BRIT MED ASS ROYA, 2004, BRIT NATL FORMULARY, V47

[3] Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity [J].

Chalasani, N ;

Aljadhey, H ;

Kesterson, J ;

Murray, MD ;

Hall, SD .

GASTROENTEROLOGY, 2004, 126 (05) :1287-1292

[4] RISK-FACTORS FOR DEVELOPMENT OF FLUCLOXACILLIN ASSOCIATED JAUNDICE [J].

FAIRLEY, CK ;

MCNEIL, JJ ;

DESMOND, P ;

SMALLWOOD, R ;

YOUNG, H ;

FORBES, A ;

PURCELL, P ;

BOYD, I .

BRITISH MEDICAL JOURNAL, 1993, 306 (6872) :233-235

[5] Alternative medicines and the liver [J].

Fogden, E ;

Neuberger, J .

LIVER INTERNATIONAL, 2003, 23 (04) :213-220

[6] Troglitazone quinone formation catalyzed by human and rat CYP3A: an atypical CYP oxidation reaction [J].

He, K ;

Woolf, TF ;

Kindt, EK ;

Fielder, AE ;

Talaat, RE .

BIOCHEMICAL PHARMACOLOGY, 2001, 62 (02) :191-198

[7] Epidemiology and individual susceptibility to adverse drug reactions affecting the liver [J].

Larrey, D .

SEMINARS IN LIVER DISEASE, 2002, 22 (02) :145-155

[8] Comparison of two clinical scales for causality assessment in hepatotoxicity [J].

Lucena, MA ;

Camargo, R ;

Andrade, RJ ;

Perez-Sanchez, CJ ;

De la Cuesta, FS .

HEPATOLOGY, 2001, 33 (01) :123-130

[9] Herbal hepatotoxicity [J].

Stedman, C .

SEMINARS IN LIVER DISEASE, 2002, 22 (02) :195-206

← 1 →